TABLE 1.
Demographics and clinical factors
| With depression | Without depression | n | p | |
|---|---|---|---|---|
| n = 30 | n = 70 | |||
| M (SD) | M (SD) | |||
| Age (yrs) | 56.6 (6.4) | 56.6 (6.4) | 100 | .98 |
| Education (yrs) | 13.3 (2.4) | 14.7 (3.1) | 100 | .02* |
| Male (%) | 73.3 | 77.1 | 100 | .68 |
| African American (%) | 66.7 | 61.4 | 100 | .62 |
| Nadir CD4 (cells/μL) a | 185.5 (2–850) | 200 (2–800) | 99 | .74 |
| HIV disease duration (yrs) | 28.1 (9.0) | 25.1 (9.3) | 100 | .13 |
| Current CD4 (cells/μL) a | 595 (167–1,093) | 732.5 (31–1,798) | 97 | .12 |
| Detectable VL (%) | 27.6 | 14.7 | 97 | .14 |
| cART adherence (%) | 96.6 | 97.1 | 99 | .88 |
| Using antideps (%) | 33.3 | 20.0 | 100 | .15 |
| Alcohol use (%) | 96.7 | 95.7 | 100 | .82 |
| Tobacco use (%) | 60.0 | 52.9 | 100 | .51 |
| Marijuana use (%) | 63.3 | 54.3 | 100 | .40 |
| With HAND (%) | 20.0 | 25.7 | 100 | .54 |
| Total BDI‐II | 14.4 (4.1) | 4.1 (2.7) | 100 | <.001** |
Note: Age = at last birthday; Education = full time years completed; Male = sex at birth; African American = participants who self‐identify as any part African American; Nadir CD4 = self‐reported lifetime nadir; Disease Duration = years since self‐reported year of first positive test; Current CD4 = obtained during visit; Detectable VL = plasma viral load (VL) of <20 copies/mL was considered undetectable; Alcohol/Tobacco/Marijuana Use = self‐reported use of the substance more than five times in one's lifetime; With HAND = participants diagnosed with HIV‐associated Neurocognitive Disorders; cART adherence = self‐reported use of combination antiretroviral therapy within 2 days prior to visit. p values are uncorrected.
Median and range.
p < .05.
p < .01.